Eligibility for, and changes to, the COVID-19 vaccination programme in Scotland has always been based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI).

In its statement of 8 November 2022 (published in January 2023), the JCVI advised that in 2023 COVID-19 vaccination should move towards a targeted offer during vaccination campaigns to protect those at higher risk of severe COVID-19.

From 30 June 2023, on the advice of the JCVI, we ceased the universal offer of COVID-19 vaccination to the entire population. From that point, only those advised as eligible by the JCVI were invited forward for COVID-19 vaccination during the JCVI-designated seasonal winter and spring campaigns.

In July 2024, Scottish Government commissioned Public Health Scotland (PHS) to deliver the Fracture Liaison Services (FLS) Audit. PHS are actively recruiting to the posts required to deliver it.

The figures below relate to Endometriosis research funding directly awarded following a competitive independent review process either through Chief Scientist Office’s (CSO) project funding committees, or fellowship funding panels.

This includes the 2022 Scottish Government collaboration with Wellbeing of Women on a £250,000 research call. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

Most awards are multi-year. The figures below relate to the year in which the funding was committed rather than a breakdown by year of the spend profile for individual projects or fellowships

2007 0

2008 0

2009 0

2010 0

2011 0

2012 £110,198

2013 0

2014 0

2015 £27,639

2016 0

2017 0

2018 £162,651

2019 £30,000

2020 0

2021 0

2022 £394,510

2023 £349,999

2024 £623,028

Full details of CSO’s direct research funding awards are available from the CSO website Funded Research – Chief Scientist Office

The Scottish Government collaborated with Wellbeing of Women on a £250,000 research call in April 2022. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

The research will be funded over 3 years with the research findings expected to be disseminated in December 2025.

In January 2023 the Chief Scientist Office announced funding of £299,509 for the 30 month ENDOCAN project, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain.

Recruitment for the study is due to start in August 2025 in NHS Lothian and NHS Grampian. More information can be found on the research being undertaken by The University of Edinburgh can be found on their website.

The Health and Social Care Alliance Scotland (the ALLIANCE) has continued to support the Women’s Health Plan through their dedicated lived experience programme, including a Women’s Health Lived Experience Stakeholder Group, to help us continue our conversation with women, and ensure women are meaningfully involved in decision making and priority setting going forward.

More information can be found in the ALLIANCE Final Report on Women’s Health Plan.

The Scottish Government provides baseline funding to NHS Boards, which Boards use to best meet the healthcare needs of their resident population. Funding is not ring-fenced for the treatment of endometriosis. It is not therefore possible to identify funding allocated specifically for endometriosis.

Through the Women’s Health Plan, a range of funding has been provided for resources and research related to improving endometriosis care.

The Scottish Government collaborated with Wellbeing of Women on a £250,000 research call in 2022. The research is primarily being run by researchers at The University of Edinburgh and will look at a non-hormonal drug in the management of endometriosis-associated pain.

The Chief Scientist Office announced funding of £299,509 for the 30 month ENDOCAN project in January 2023, led by researchers at The University of Edinburgh. Through a large scale UK-wide trial, the research will investigate whether a cannabinoid can reduce endometriosis-associated pain.

The Scottish Government also provided £24,000 of funding in August 2023 to Endometriosis UK to deliver a project creating new resources to support people with endometriosis.

The costs associated with establishing an identity for Qualifications Scotland were set out in the Financial Memorandum that accompanied the Education (Scotland) Bill and were the best estimate available at the time.

A cost relating to the creation of an identity of a new public body will always be incurred and Qualifications Scotland is no exception. I requested that my officials look at ways to bear down on costs where possible while still delivering an identity for Qualifications Scotland. I can confirm that officials have been working closely with the SQA on this, to ensure that value for money for taxpayers is achieved.

The Best Start emphasises parents as key partners in caring for their baby and aims to keep mothers and babies, and families together as much as possible in the crucial early weeks, with services designed around them.

The Scottish Government remains committed to the new model of care and its aim to minimise the separation of families, and to support parents with babies in neonatal care.

We have a number of measures already in place to support families:

• Development of Transitional Care beds within maternity units so that babies with moderate additional care needs can be cared for alongside their mothers in a postnatal ward with neonatal support;
• Providing accommodation for parents to stay on or near neonatal units;
• Roll out of the Young Patients Family Fund (formerly the Neonatal Expenses Fund) to support families with the costs of travel, accommodation and food whilst their baby is in neonatal care;

and

• Repatriating babies to their local neonatal units as soon as clinically possible;
• Development of neonatal community care so that babies can get home quicker with neonatal community support.

NHS boards are committed to involve parents in decision making and providing care for their baby; to provide funding support and accommodation for parents to stay on or near the unit, facilities within the unit to encourage kangaroo skin to skin care, early support for breastfeeding and to develop clear information for parents.

The Best Start (2017) recommended all neonatal facilities should provide emergency overnight accommodation on the unit for parents, with accommodation available nearby for parents of less critically ill babies. Boards are expected to include provision for this in their planning.

We also provide support to all families with babies in neonatal care to cover the costs of food, travel and accommodation as part of our Young Patients Family Fund.

Hospitals with the neonatal intensive care units have accommodation for families on site, and this will be offered to families in the first instance. If hospital accommodation is not available, the Health Board will usually be able to book and pay for nearby accommodation for families in advance.

The public consultation on the detail of proposed regulations to restrict promotions of food and drink high in fat, sugar or salt closed on 21 May 2024. The consultation paper sought views on proposals for price promotions within scope of restrictions, including meal deals and temporary price reductions.

We will publish the independent analysis report of the consultation responses in early 2025, as well as next steps for the regulation of HFSS food and drink promotions.